These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 22290254)

  • 1. Neuroimaging: diagnosis and response assessment in glioblastoma.
    Clarke JL; Chang SM
    Cancer J; 2012; 18(1):26-31. PubMed ID: 22290254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging and genetic influence in treating brain neoplasms.
    Hygino da Cruz LC; Kimura M
    Neuroimaging Clin N Am; 2015 Feb; 25(1):121-40. PubMed ID: 25476517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New imaging techniques for more effective treatment in glioblastoma.
    Fay MF; Martin JH; Rose S
    Intern Med J; 2014 Jan; 44(1):5-6. PubMed ID: 24450518
    [No Abstract]   [Full Text] [Related]  

  • 4. 18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria.
    Bolcaen J; Acou M; Boterberg T; Vanhove C; De Vos F; Van den Broecke C; Van Holen R; Deblaere K; Goethals I
    Nucl Med Commun; 2017 Mar; 38(3):242-249. PubMed ID: 27984537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of advanced MRI techniques for the peritumoural region in differentiating glioblastoma multiforme and solitary metastatic lesions.
    Lee EJ; Ahn KJ; Lee EK; Lee YS; Kim DB
    Clin Radiol; 2013 Dec; 68(12):e689-97. PubMed ID: 23969153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.
    Shiroishi MS; Boxerman JL; Pope WB
    Neuro Oncol; 2016 Apr; 18(4):467-78. PubMed ID: 26364321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in therapy for glioblastoma.
    Clarke J; Butowski N; Chang S
    Arch Neurol; 2010 Mar; 67(3):279-83. PubMed ID: 20212224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.
    Verduin M; Compter I; Steijvers D; Postma AA; Eekers DBP; Anten MM; Ackermans L; Ter Laan M; Leijenaar RTH; van de Weijer T; Tjan-Heijnen VCG; Hoeben A; Vooijs M
    Dis Markers; 2018; 2018():2908609. PubMed ID: 29581794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab.
    Wen Q; Jalilian L; Lupo JM; Molinaro AM; Chang SM; Clarke J; Prados M; Nelson SJ
    J Neurooncol; 2015 Jan; 121(2):331-9. PubMed ID: 25351579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present and potential future issues in glioblastoma treatment.
    Lefranc F; Sadeghi N; Camby I; Metens T; Dewitte O; Kiss R
    Expert Rev Anticancer Ther; 2006 May; 6(5):719-32. PubMed ID: 16759163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant glioblastoma.
    Boutemy R; Loyens M; Christophe C; Sariban E; Parlmutter N
    J Belge Radiol; 1997 Dec; 80(6):295. PubMed ID: 9479893
    [No Abstract]   [Full Text] [Related]  

  • 12. The concepts, diagnosis and management of early imaging changes after therapy for glioblastomas.
    Sanghera P; Rampling R; Haylock B; Jefferies S; McBain C; Rees JH; Soh C; Whittle IR
    Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):216-27. PubMed ID: 21783349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taming Glioblastoma in "Real Time": Integrating Multimodal Advanced Neuroimaging/AI Tools Towards Creating a Robust and Therapy Agnostic Model for Response Assessment in Neuro-Oncology.
    de Godoy LL; Chawla S; Brem S; Mohan S
    Clin Cancer Res; 2023 Jul; 29(14):2588-2592. PubMed ID: 37227179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary intraspinal localizations of glioblastoma. Apropos of a case].
    Aghakhani N; Roux FX; Fallet-Bianco C; Devaux B
    Neurochirurgie; 1995; 41(5):363-6. PubMed ID: 8577358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed modeling of alternating electric fields therapy for recurrent glioblastoma.
    Lok E; Hua V; Wong ET
    Cancer Med; 2015 Nov; 4(11):1697-9. PubMed ID: 26311253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive profile of recurrent glioblastoma.
    Campos B; Olsen LR; Urup T; Poulsen HS
    Oncogene; 2016 Nov; 35(45):5819-5825. PubMed ID: 27041580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult Glioblastoma.
    Alexander BM; Cloughesy TF
    J Clin Oncol; 2017 Jul; 35(21):2402-2409. PubMed ID: 28640706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic primary anorectal melanoma developing in a patient treated for multicentric glioblastoma multiforme: two rare malignancies presenting in synchronicity.
    Ahmad I; Bashir I; Dhingra N; Hangloo V
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29563128
    [No Abstract]   [Full Text] [Related]  

  • 19. Diffuse bilateral cerebral astrocytomas with atypical neuroimaging studies.
    Rogers LR; Weinstein MA; Estes ML; Cairncross JG; Strachan T
    J Neurosurg; 1994 Dec; 81(6):817-21. PubMed ID: 7965110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant gliomas in children.
    Johnson JH; Phillips PC
    Cancer Invest; 1996; 14(6):609-21. PubMed ID: 8951364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.